HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma
Aging · 2024
DOI: 10.18632/aging.205637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Liang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai 201315, China.
- State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100191, China.
Zitieren
APA
Liu, L., Zhang, Z., Jiang, C., Zhu, Y., Han, R., Wu, L., & Xu, Y. (2024). HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.205637
Vancouver
Liu L, Zhang Z, Jiang C, Zhu Y, Han R, Wu L, et al. HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. Aging. 2024. doi:10.18632/aging.205637
BibTeX
@article{Liu2024,
author = {Liu, Liang and Zhang, Zhenshan and Jiang, Chenxue and Zhu, Yaoyao and Han, Ruiqin and Wu, Leilei and Xu, Yaping},
title = {HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205637}
}
EUVIMED